A Multiple Dose Study Of PF-04620110 In Type 2 Diabetes Patients



Status:Archived
Conditions:Diabetes
Therapuetic Areas:Endocrinology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:February 2011
End Date:June 2011

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

A Phase 1B, Randomized, Double-Blind, Placebo-Controlled Trial To Assess The Efficacy And Safety Of 4-Week Administration Of Multiple Oral Doses Of PF-04620110 In Type 2 Diabetes Mellitus Subjects With Insufficient Glycemic Control On Metformin


PF-04620110 is a novel compound proposed for the treatment of Type 2 diabetes mellitus. The
primary purpose of this trial is to evaluate the safety and tolerability, and
pharmacodynamics, of multiple oral doses of PF-04620110 in T2DM patients.



We found this trial at
2
sites
Pfizer Investigational Site
Los Angeles, California 90027
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Raleigh Regional Cancer Center
Beckley, West Virginia 25801
?
mi
from
Beckley, WV
Click here to add this to my saved trials